People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Nation's top GP has issued a stark warning about the dangers of buying unregulated weight loss medication online ...

A woman appeals for advice and reassurance after buying and taking what she believes is semaglutide from an unofficial ... rather than the regular pen As well as dodgy sellers operating online ...

In a welcome move for many patients who have a fear of needles, latest research by the ... is slightly longer than a regular ballpoint pen. The device has a micro shock tube consisting of three ...

Patients barely feel a thing, and the process causes less skin trauma compared to traditional needles. The device, about the size of a ballpoint pen, is equipped with a specially designed nozzle (as ...

In 2021, the Denmark-headquartered company launched Wegovy, a semaglutide pen-injection, which became the first FDA-approved drug for long-term weight management in almost a decade. In November 2023, ...

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy ...

needles and bodily fluids. As described in the ruling, Koivu was “concerned that there is a developing, false narrative that encampments are a safe alternative form of housing,” and that ...

People who use semaglutide, the active ingredient in diabetes and weight-loss medications like Ozempic, face twice the risk of developing a serious eye condition that can lead to blindness, according ...

Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.